Market
Axoft raises $55m to advance BCI made of Fleuron
Axoft has raised $55 million in funding to advance clinical trials and US regulatory activities for its implantable brain-computer interface (BCI) device. The capital will support ongoing trial programmes and FDA pathway development for the technology.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network